Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Feb 9, 2010

Premium

Roche NimbleGen said last week that it has certified genomics service provider Atlas Biolabs to provide target-enrichment and sequencing services using its technologies.

Atlas Biolabs, based in Berlin, will provide DNA capture services using NimbleGen sequence capture arrays, and then sequence the samples on Roche's 454 GS FLX.

Atlas Biolabs joins two other European NimbleGen-certified service providers: Eurofins MWG Operon and ImaGenes.


Silicon Kinetics last week launched new surface chemistries for its SKi Pro label-free biomolecular interaction analysis platform.

The new chemistries include NTA-Ni for His-tagged proteins, and protein A and protein G for coupling antibodies.

San Diego-based Silicon Kinetics said its 3D SKi Sensor biochips are used to detect protein-protein, protein-drug, or protein-DNA interactions in real time and quantify binding kinetics, dissociation rates, or biomolecular affinity ranking.


Dimole this week launched DIM-Array PVY PLRV. The system offers DNA-based simultaneous detection of potato Y potyvirus, including strains PVYO, PVYN, and PVYntn, as well as potato leafroll luteovirus and an internal control from dormant potato tubers.

The system allows for testing of a group of dormant tubers in a single assay within eight hours, Laval, Quebec-based Dimole said. The DIM-Array PVY PLRV system was evaluated by the potato laboratory Research and Development Institute for the Agri-Environment of Quebec, according to the firm.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more